
A recent review (https://doi.org/10.1080/14740338.2024.2338245) emphasizes that non-compliance is the leading modifiable cause of treatment failure.
Key insights:
- Adverse events, though mostly mild and temporary, often lead to early discontinuation.
- Educating patients on what to expect improves adherence.
- Simplified regimens & clear communication = better outcomes.
- Patient reassurance: most side effects are not dangerous, and stopping treatment often causes more harm than good.
From the European Registry (@Hp-EuReg), real-world data shows:
- Only 1.7% of patients discontinued treatment
- Women and penicillin-allergic patients showed higher non-compliance
- Rescue treatments had higher drop-out rates than first-line therapy
(Source: https://doi.org/10.1002/ueg2.12569)